搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pseudomonas fluorescens 50S ribosomal protein L31 type B (rpmE2) CSB-YP501130FFU
CSB-EP501130FFU
CSB-BP501130FFU
CSB-MP501130FFU
CSB-EP501130FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Pyridoxine/pyridoxamine 5'-phosphate oxidase (pdxH) CSB-YP501131FFU
CSB-EP501131FFU
CSB-BP501131FFU
CSB-MP501131FFU
CSB-EP501131FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Xylose isomerase (xylA) CSB-YP501132FFU
CSB-EP501132FFU
CSB-BP501132FFU
CSB-MP501132FFU
CSB-EP501132FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Sec-independent protein translocase protein TatA (tatA), partial CSB-YP501133FFU
CSB-EP501133FFU
CSB-BP501133FFU
CSB-MP501133FFU
CSB-EP501133FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Phosphoribosyl-ATP pyrophosphatase (hisE) CSB-YP501134FFU
CSB-EP501134FFU
CSB-BP501134FFU
CSB-MP501134FFU
CSB-EP501134FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Probable ubiquinone biosynthesis protein UbiB (ubiB), partial CSB-YP501135FFU1
CSB-EP501135FFU1
CSB-BP501135FFU1
CSB-MP501135FFU1
CSB-EP501135FFU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Ubiquinone/menaquinone biosynthesis methyltransferase ubiE (ubiE) CSB-YP501136FFU
CSB-EP501136FFU
CSB-BP501136FFU
CSB-MP501136FFU
CSB-EP501136FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens ATP-dependent protease ATPase subunit HslU (hslU) CSB-YP501137FFU
CSB-EP501137FFU
CSB-BP501137FFU
CSB-MP501137FFU
CSB-EP501137FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Adenine deaminase (PFLU_0667) CSB-YP501138FFU
CSB-EP501138FFU
CSB-BP501138FFU
CSB-MP501138FFU
CSB-EP501138FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP501139FFU
CSB-EP501139FFU
CSB-BP501139FFU
CSB-MP501139FFU
CSB-EP501139FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens ATP phosphoribosyltransferase (hisG) CSB-YP501140FFU
CSB-EP501140FFU
CSB-BP501140FFU
CSB-MP501140FFU
CSB-EP501140FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens RNA polymerase-associated protein RapA (rapA), partial CSB-YP501141FFU
CSB-EP501141FFU
CSB-BP501141FFU
CSB-MP501141FFU
CSB-EP501141FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Aliphatic amidase (amiE) CSB-YP501142FFU
CSB-EP501142FFU
CSB-BP501142FFU
CSB-MP501142FFU
CSB-EP501142FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Inositol 2-dehydrogenase (iolG) CSB-YP501143FFU
CSB-EP501143FFU
CSB-BP501143FFU
CSB-MP501143FFU
CSB-EP501143FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Fe/S biogenesis protein NfuA (nfuA) CSB-YP501144FFU
CSB-EP501144FFU
CSB-BP501144FFU
CSB-MP501144FFU
CSB-EP501144FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP501145FFU
CSB-EP501145FFU
CSB-BP501145FFU
CSB-MP501145FFU
CSB-EP501145FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Probable 4-amino-4-deoxy-L-arabinose-phosphoundecaprenol flippase subunit ArnE (arnE), partial CSB-YP501146FFU1
CSB-EP501146FFU1
CSB-BP501146FFU1
CSB-MP501146FFU1
CSB-EP501146FFU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Bifunctional polymyxin resistance protein ArnA (arnA), partial CSB-YP501147FFU
CSB-EP501147FFU
CSB-BP501147FFU
CSB-MP501147FFU
CSB-EP501147FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase (arnC), partial CSB-YP501148FFU1
CSB-EP501148FFU1
CSB-BP501148FFU1
CSB-MP501148FFU1
CSB-EP501148FFU1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas fluorescens ATP-dependent protease subunit HslV (hslV) CSB-YP501149FFU
CSB-EP501149FFU
CSB-BP501149FFU
CSB-MP501149FFU
CSB-EP501149FFU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>